1. EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling. (27th March 2020) Authors: Yue, Xuetian; Wu, Fangnan; Wang, Jianming; Kim, Kaitlin; Santhamma, Bindu; Dileep, Kalarickal V; Zhang, Kam Y J; Viswanadhapalli, Suryavathi; Vadlamudi, Ratna K; Ahmed, Gulzar; Feng, Zhaohui; Nickisch, Klaus; Hu, Wenwei Editors: Fu, Haian Journal: Journal of molecular cell biology Issue: Volume 12:Number 6(2020) Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Gain of function mutant p53 protein activates AKT through the Rac1 signaling to promote tumorigenesis. Issue 11 (2nd June 2020) Authors: Yue, Xuetian; Wu, Fangnan; Li, Yanchen; Liu, Juan; Boateng, Michael; Mandava, Kranthi; Zhang, Cen; Feng, Zhaohui; Gao, Jimin; Hu, Wenwei Journal: Cell cycle Issue: Volume 19:Issue 11(2020) Page Start: 1338 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗